Copyright
©2012 Baishideng Publishing Group Co.
World J Stem Cells. Nov 26, 2012; 4(11): 110-116
Published online Nov 26, 2012. doi: 10.4252/wjsc.v4.i11.110
Published online Nov 26, 2012. doi: 10.4252/wjsc.v4.i11.110
Figure 2 Recombinant progranulin and decroin protect against amyloid-β42-neurotoxicity in vitro.
A: Instead of human umbilical cord blood-derived mesenchymal stem cells, 10 ng of progranulin and decroin were used to treat amyloid-β42 (Aβ42)-exposed rat primary neuronal cells, After 36 h, each cell was assayed by Live/Dead staining. The green and red colorindicate live and dead cells, respectively; B: Percentage of dead cells in decroin- and progranulin-treated cells exposed to Aβ42; C: To show survived neurons in rat primary neuronal cells, cells were stained by anti-microtubule associated protein 2 antibody. PGRN: Progranulin; DCN: Decorin.
-
Citation: Kim JY, Kim DH, Kim JH, Yang YS, Oh W, Lee EH, Chang JW. Umbilical cord blood mesenchymal stem cells protect amyloid-β42 neurotoxicity
via paracrine. World J Stem Cells 2012; 4(11): 110-116 - URL: https://www.wjgnet.com/1948-0210/full/v4/i11/110.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v4.i11.110